Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies-Reference-Cited by-同舟云学术

Conditioning with Treosulfan and Fludarabine followed by Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Published:2011-03 Issue:3 Volume:17 Page:341-350
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Nemecek Eneida R.,Guthrie Katherine A.,Sorror Mohamed L.,Wood Brent L.,Doney Kristine C.,Hilger Ralf A.,Scott Bart L.,Kovacsovics Tibor J.,Maziarz Richard T.,Woolfrey Ann E.,Bedalov Antonio,Sanders Jean E.,Pagel John M.,Sickle Eileen J.,Witherspoon Robert,Flowers Mary E.,Appelbaum Frederick R.,Deeg H. Joachim

Funder

Medac GmbH

National Cancer Institute and National Heart Lung Blood Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference51 articles.

1. The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation;Ringdén;Blood,2009

2. Long-term outcome and late effects in patients transplanted with mobilised blood or bone marrow: a randomised trial;Friedrichs;Lancet Oncol,2010

3. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis;Shi-Xia;Leuk Lymphoma,2010

4. Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide;Bredeson;Biol Blood Marrow Transplant,2008

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

2. Determinants of Interpatient Variability in Treosulfan Pharmacokinetics in AML Patients Undergoing Autologous Stem Cell Transplantation;International Journal of Molecular Sciences;2024-07-27

3. Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT;Bone Marrow Transplantation;2024-03-15

4. Treosulfan Exposure Predicts Thalassemia‐Free Survival in Patients with Beta Thalassemia Major Undergoing Allogeneic Hematopoietic Cell Transplantation;Clinical Pharmacology & Therapeutics;2023-11-07

5. Population pharmacokinetic modeling of treosulfan and rationale for dose recommendation in children treated for conditioning prior to allogeneic hematopoietic stem cell transplantation;Drug Metabolism and Pharmacokinetics;2023-10